The majority of severe COVID-19 patients develop anti-cardiac autoantibodies.
Fagyas M, Nagy B Jr, Ráduly AP, Mányiné IS, Mártha L, Erdősi G, Sipka S Jr, Enyedi E, Szabó AÁ, Pólik Z, Kappelmayer J, Papp Z, Borbély A, Szabó T, Balla J, Balla G, Bai P, Bácsi A, Tóth A.
Fagyas M, et al. Among authors: bacsi a.
Geroscience. 2022 Oct;44(5):2347-2360. doi: 10.1007/s11357-022-00649-6. Epub 2022 Sep 16.
Geroscience. 2022.
PMID: 36112333
Free PMC article.